These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38197434)

  • 1. Clinical value of random esophageal biopsies in patients with dysphagia and normal endoscopy who are treated with a proton pump inhibitor.
    Kamionkowski S; Shibli F; Saleh S; Trujillo S; Mengalle E; El Mokahal A; Thomas C; Song G; Fass R
    Dis Esophagus; 2024 Apr; 37(4):. PubMed ID: 38197434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.
    Kidambi T; Toto E; Ho N; Taft T; Hirano I
    World J Gastroenterol; 2012 Aug; 18(32):4335-41. PubMed ID: 22969196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
    Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
    Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Gastrointestinal Conditions: Nonmalignant Conditions of the Esophagus.
    Estores DS; Chang KL
    FP Essent; 2017 Jul; 458():11-17. PubMed ID: 28682046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
    Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
    Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.
    Watson DI; Lally CJ
    World J Surg; 2009 Jan; 33(1):88-94. PubMed ID: 18949510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
    Mahoney LB; Nurko S; Rosen R
    J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
    Spechler SJ; Hunter JG; Jones KM; Lee R; Smith BR; Mashimo H; Sanchez VM; Dunbar KB; Pham TH; Murthy UK; Kim T; Jackson CS; Wallen JM; von Rosenvinge EC; Pearl JP; Laine L; Kim AW; Kaz AM; Tatum RP; Gellad ZF; Lagoo-Deenadayalan S; Rubenstein JH; Ghaferi AA; Lo WK; Fernando RS; Chan BS; Paski SC; Provenzale D; Castell DO; Lieberman D; Souza RF; Chey WD; Warren SR; Davis-Karim A; Melton SD; Genta RM; Serpi T; Biswas K; Huang GD
    N Engl J Med; 2019 Oct; 381(16):1513-1523. PubMed ID: 31618539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
    Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
    Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
    Shaheen NJ; Weinberg DS; Denberg TD; Chou R; Qaseem A; Shekelle P;
    Ann Intern Med; 2012 Dec; 157(11):808-16. PubMed ID: 23208168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of acid gastro-oesophageal reflux disease in Jackhammer oesophagus.
    Mallet AL; Ropert A; Bouguen G; Siproudhis L; Boutroux D; Bretagne JF; Brochard C
    Dig Liver Dis; 2016 Oct; 48(10):1136-41. PubMed ID: 27453169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY
    J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untangling Nonerosive Reflux Disease From Functional Heartburn.
    Patel D; Fass R; Vaezi M
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1314-1326. PubMed ID: 32246998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.